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Here we report a computational method to improve efficiency of a de novo designed Kemp 
Eliminase enzyme KE15, by identifying mutations that enhance electric fields and chemical 
positioning of the substrate that contribute to free energy stabilization of the transition state. 
Starting from the design that has a kcat/KM of 27 M-1s-1, the most improved variant introduced 4 
computationally targeted mutations to yield a kcat/KM of 403 M-1s-1, with almost all of the enzyme 
improvement realized through a 43-fold improvement in kcat, indicative of a direct impact on the 
chemical step. This work raises the prospect of computationally designing enzymes that achieve 
better efficiency with more minimal experimental intervention using electric field optimization 
as guidance. 
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INTRODUCTION 
De novo designed enzymes via computer modeling of active sites accommodated within a 
variety of protein scaffolds1-2, have been reported for reactions such Kemp elimination3-6, retro-
aldol condensation7 and Diels-Alders	chemistry8. However, most computational designs to date 
have exhibited very little catalytic competence compared to native enzymes or enzymes 
subsequently improved through laboratory directed evolution (LDE). A case in point is the Kemp 
elimination reaction, a one-step proton transfer reaction from the 5-nitrobenzisoxazole substrate 
by a catalytic base, leading to breaking of the 5-membered ring and forming the final product, 
alpha-cyanophenol (Figure 1a). Various Kemp eliminases that were computationally designed 
catalyze this reaction with efficiencies as measured by kcat/KM of 12, 126, 160, and 425 M-1s-1, 
for KE075, KE706, KE594, and HG39, respectively. However substantial gain in biocatalytic 
activity is achieved when these minimal designs are subjected to laboratory directed evolution 
LDE; after undergoing LDE, the Kemp eliminases KE075, KE706, KE594, and HG310 yielded 
kcat/KM values of 2.0x103, 5.7x104, 6.0x105, and 2.3x106 M-1s-1, respectively, which has led to 
much optimism for achieving efficiencies that rival natural enzymes.  
However, there is still great appeal for replacing the labor-intensive and opaque LDE 
optimization process11-12 with a rational approach using computation to create more competent 
enzymes, or at least by starting the LDE process with a much more improved enzyme by 
computational design. There are a number of possible concepts that can be used to rationally 
explain the LDE process and/or which can be used for further improving designed enzymes.13 
For example, Frushicheva et. al14-16 and Labas et. al17 used simulations based on the empirical 
valence bond method to show that LDE improved KE07 via ground state destabilization and 
reorganization energy optimization. DA_20_10, an enzyme that catalyzes the Diers-Alders 
reaction, was further improved by crowdsourcing it to FoldIt players that led to a remodeling of 
the backbone and an 18-fold improvement in activity18, almost all of which was due to 
improvements in KM. Others have used computational approaches to augment the construction of 
LDE libraries, using backrub motion19, loop redesign20, and consensus mutations21-22. Mayo and 
co-workers have developed computational techniques that uses a genetic algorithm framework to 
propose mutations that help avoid unstable folds by conserving the number of contacts that are 
broken/made before and after doing the proposed shuffling LDE experiments23. Other attempts at 
predicting side directed mutations have tried to minimize absolute entropy of the mutation site24 
to improve stability. Privett and co-workers utilized an iterative approach of creating a new 
active site deeper in the scaffold of a designed Kemp Eliminase that is better shielded from 
solvent, thereby increasing the hydrophobicity of the binding pocket to enhance the pKa of the 
catalytic base, and use of molecular dynamics25 to diagnose problems with side chain 
orientations that were poorly preorganized9. Finally, Warshel and coworkers were the first to 
identify the preorganization of the electrostatic free energy as a key component of enzyme 
catalysis26-28; in fact many groups have reported evidence for how electric fields contribute to the 
catalytic power of various natural enzymes.29-33 
 (a) 
 
(b)       (c) 
 
Figure 1: The Kemp Elimination reaction and designed KE15 enzyme. (a) The one-step reaction 
scheme involving the abstraction of hydrogen from the carbon of 5-nitrobenzisoxazole by a 
catalytic base. Shown is the transition state that has a partial negative charge on the substrate 
oxygen with cleavage of the O-N bond and nascent formation of a C≡N triple bond (Reprinted 
with permission from 34 Copyright 2017 American Chemical Society.) (b) Active site of KE15 
design utilizing catalytic base Asp-48 and Tyr-126 as π-stacking residue for the residue 
engineered into the TIM barrel scaffold (PDB ID: 1THF). (c) View of the overall KE15 enzyme. 
The active site and other designed residues are shown in red with substrate in cyan.35 
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We have recently reported in two separate studies the effects of both side chain 
conformational entropy and mutual information36, as well as electrostatic stabilization34, for 
improving designed KE07 and KE70 enzymes during the LDE process. It was shown in the first 
study that improved variants used a combination of free energy destabilization of the reactant 
enzyme-ligand bound state (EL) (in agreement with Frushicheva et. al14-16 and Labas et. al17) and 
stabilization of the transition state (EL†) to enhance activity, with significant contributions from 
side chain entropy that supported this trend36. In the second study, we demonstrated how electric 
field stabilization of the three bonds of the substrate that are broken and formed to create the 
product was greatly improved in the evolved KE07 enzyme, while for KE70 the LDE strategy 
evolved toward mutations that created a more hydrophobic active site instead34. In our study on 
KE07 and KE70, a breakdown of contribution of the electric field from individual residues 
further revealed that chemical positioning of the catalytic base and active site residues in the 
immediate vicinity of the substrate were the primary source of electrostatic improvement for 
both enzymes. In contrast, the solvent and the remaining scaffold provided electrostatic 
environments that were detrimental to the active site chemistry for KE07 and KE70, unlike 
native enzymes34.  
In this paper, we apply the understanding gained from these previous studies to improve 
the de novo enzyme KE15 using only computational predictions. Since no LDE was performed 
on KE15, it serves as a good test system for improving catalytic efficiency in a rational and 
systematic way for a de novo enzyme designed with the standard Rosetta protocol used for the 
previous KE07, KE70, KE59, and HG designed enzymes. The active site is built around the 
catalytic base Asp-48 and a Tyr-126 π-stacking residue to orient the ligand (Figure 1b), which is 
introduced into a TIM barrel scaffold, with 13 additional design mutations made to accommodate 
the new active site and stabilize the enzyme (Figure 1c). Experimentally, the designed enzyme 
was found to have a kcat/KM of 27 M-1s-1 where kcat=0.007 s-1 and KM = 270 μM.  
Starting with the KE15 design, we have screened mutants in silico35, primarily targeted 
by improvements in electrostatic stabilization of the transition state and better chemical 
positioning of the base in the active site. We tested our predictions experimentally, and with 4 
mutations found the best variant that yielded an overall 43X increase in kcat =0.31 s-1 with some 
degradation in KM =767 μM, leading to 15X improvement of kcat/KM =403 M-1s-1. To put this in 
perspective, the improvement in kcat for KE15 is equivalent to 6-7 rounds of LDE for KE07 (in 
which kcat improved 70X) and KE70 (in which kcat improved 35X). We show from our 
calculations that while some of the improvement came from destabilization of the reactant state, 
most improvement came from stabilization of the transition state, as intended. 
COMPUTATIONAL METHODS 
Our computational screening strategy to determine beneficial mutants for designed enzymes 
makes use of electric field calculations using short MD trajectories with the AMOEBA force 
field. We only give a brief description here, and more specific details for each of the simulation 
techniques have been provided in a previous publication34. 
 Sampling approaches to creating structural ensembles for KE15. The designed KE15 
starting structure with docked ligand was provided by the Houk group (UCLA), and 
computational mutations were built using Modeler37. For each sequence variant, we computed 
10,000 trial moves to create each 25 uncorrelated and low energy backbone structures using 
backrub simulations provided within the Rosetta modeling software package38-40. To generate 
additional structural ensemble diversity, we used our recently developed Monte Carlo method 
(MC-SCE)41, for which we have performed extensive validation across ~60 proteins through 
comparison to high quality X-ray crystallography data and NMR experiments, to characterize the 
side chain structural ensemble on the 25 backbone structures for KE15. Briefly, the method uses 
a Rosenbluth side chain growth protocol sampled from an expanded side chain rotamer library42-
43, which are energy weighted according to a physical energy function based on the 
AMBERff99SB protein force field combined with a GB-HPMF implicit solvent model; 
backbone variability is introduced through a backrub algorithm38-40.  
 We ran additional MD simulations of the enzyme and docked ligand (EL state) using 
OpenMM44 and the AMOEBA polarizable force field45-46 in the NVT ensemble (T=300K, 1 fs 
timestep). The system was solvated using Gromacs47-48 with a pre-equilibrated water box (70 Å × 
70 Å × 70 Å). After a 40 ps equilibration time, we collected snapshots every 50 fs across a 10ps 
production run (200 snapshots for each of the 25 structures so 5000 frames per mutant per state). 
The binding energy, 𝐸"#$%, was calculated as follows:  𝐸"#$% =	< 𝐸)$*+,)-.#/0$% − 𝐸)$*+,) − 𝐸.#/0$% >345                            (1) 
where 𝐸)$*+,)-.#/0$%, 𝐸)$*+,) and 𝐸.#/0$%	are the MM energies of the ligand bound enzyme, 
enzyme and ligand respectively. Each energy term was found by minimizing the energy of the 
snapshots in the OBC2 implicit solvent model in OpenMM.  
 Electric field calculations. Using Gromacs47, the 25 lowest energy structures were 
explicitly solvated using a pre-equilibrated water box. We then performed 50 ps equilibration 
and then 50 ps production runs in the NPT ensemble using the Tinker software package49-51 and 
the AMOEBA polarizable force field45, 49 to provide a high quality description of electrostatics in 
the active site and overall scaffold and solvent. The substrate geometry for the transition state 
was the same as in the reactant state, but the atomic multipoles of the transition state are different 
than the reactant state and were taken from AMOEBA polarization calculations reported in [34]; 
since this study focuses primarily on electrostatic effects this is an acceptable transition state 
model. In some of our simulations, we restrained the ligand in place using 2 harmonic potentials 
with 1000 N/m spring constants, between the carbon of the carbolic acid group of the base and 
the (i) H (2.0-3.0 Å) and (ii) N (4.0-5.0 Å) atoms of the ligand. Electric fields are calculated 
every picosecond over the 50ps production run at each of the 4 atoms that make up the 3 bonds 
of the substrate that are most changed on going from the reactant to transition state (Figure 2). 
The electric field is projected onto each bond and the value reported is given by the mean of the 
electric field at the two atoms involved34.  
 
 
Figure 2: Electric field projection onto the C-H, C-N, and O-N bond dipoles of 5-
nitrobenzisoxazole and sign convention used. Electric fields are calculated at the C, H, N and O 
of the ligand, in which the critical chemical step of the reaction is the breaking of the C-H and O-
N bonds and the making of the C-N triple bond. Reprinted with permission from 34 Copyright 
2017 American Chemical Society. 
 
 
EXPERIMENTAL METHODS  
The 5-nitrobenzisoxazole ligand was synthesized by following an earlier published method52, 
and its improved version from the Hilvert laboratory53. The KE15 plasmids were kindly provided 
by the David Baker laboratory at University of Washington, Seattle, WA, and variants studied in 
this work were generated by site-directed mutagenesis using a Quik Change II site-directed 
mutagenesis kit (Stratagene; Agilent Technologies, Santa Clara) using appropriate PCR primers. 
After the mutagenesis PCR reactions, the mutated plasmids were transformed into XL-10 gold 
cells and the plasmids encoding individual mutations were isolated. The identity of the mutated 
plasmids were confirmed by sequencing the plasmid from both forward and reverse directions 
using T7 forward and T7 reverse primers at UC Berkeley Sequencing facility. The individual 
mutated plasmids were transformed into expression cell line BL21 (DE3) gold. 
A single colony from the transformed cells containing individual variant was used to 
inoculate a starter culture of 20 mL LB medium supplemented with 50 μg/mL kanamycin and the 
resulting culture incubated with shaking overnight at 37°C. This starter culture was used to 
inoculate 500 mL LB medium with 50 μg/mL kanamycin and incubated for ~3h at 37°C until 
OD600 reached ~1.2. The culture was then induced with 1mM IPTG for overproduction and the 
culture was further grown with shaking at 37°C for 4h. The cells from the liquid culture were 
harvested and stored at -80°C until used for the isolation. In general, roughly 2 g of the wet cells 
were routinely obtained from 0.5L culture.  
 The harvested cells were thawed, re-suspended in 35 mL lysis buffer (25 mM Hepes, pH 
7.25 containing 100 mM NaCl, 5% glycerol), lysed by sonication, centrifuged to remove 
insoluble debris and the soluble fraction loaded into pre-washed Ni-NTA column (5mL resin, 
His-Pur, Thermo-Fisher). The Ni-NTA resin with the bound proteins were washed first with 10 
column volume of lysis buffer followed by 15 column volume of 20 mM NaPi, pH 7.4, 500 mM 
NaCl, 30 mM Imidazole to remove nonspecific and weakly bound proteins. The bound His-
tagged fusion protein was then eluted from the Ni-NTA resin with 20-25 mL of 500mM 
Imidazole buffer solution (20 mM NaPi pH 8.0, 500 mM NaCl, 500 mM Imidazole). The eluted 
fusion protein were extensively dialysed in lysis buffer, concentrated through Amicon filters 
(30,000 MWCO, Millipore), its concentration estimated by measuring the absorbances at 280 nm 
and stored at -80°C in smaller aliquots. This purification protocol yielded over 90% pure protein 
(assessed through the visible bands in SDS-PAGE) and routinely produced 10-20 mg of His-
tagged KE15 proteins. 
The enzymatic characterization of the KE15 variants was performed similar to previously 
published work5 with some modification in the Cary 50 spectrophotometer (Varian) that used a 
quarz cuvette.  In short, the kinetic analysis were performed in 25 mM Hepes, pH 7.25, 100 mM 
NaCl, 5% glycerol with 5-nitrobenzisoxazole concentration ranging from 5-1500 μM with the 
co-solvent acetonitrile concentration equalized to 1.5% (v/v) in a micro-cuvette capable of 
monitoring reaction at 200 μL. A known amount of dry 5-nitroxybenzisoxazole was dissolved in 
acetonitrile to have 100mM substrate stock. From this stock a series of dilutions of the substrate 
were made in acetonitrile to achieve the concentration ranges in the kinetic assay. The reaction 
was initiated by the addition of small amount of the enzyme aliquot (final concentration from 
0.5-1.5 μM in the assay) and the product formation was monitored spectrophotometrically at 380 
nm (Δε = 15,800 M-1, cm-1). Steady-state parameters were obtained after fitting the data to the 
Michelis-Menten equation. 
RESULTS 
Similar to other computationally designed enzymes such as KE07 and KE70, the efficiency of 
the KE15 design is quite poor (Table 1). To improve the catalytic activity of the KE15 enzyme, 
we want to identify sites for possible mutations that would stabilize the transition state through 
better electric fields at some or all of the bonds under the convention defined in Figure 2.  
 
Table 1: Kinetics data determined experimentally for the KE15 enzyme design and mutants 
predicted from electric field and chemical positioning calculations. The most beneficial mutation 
from each iteration was added to move to the next round of screening. Only a handful of 
mutations were tested in the lab, dramatically reducing the labor that usually goes into improving 
designed enzymes.  
Round Enzyme Mutant kcat  (s-1) KM (μM) kcat /KM (M-1 s-1) 
1 KE15 Design 0.0072 ± 0.0004 270 ± 39 26.7 ± 5.3 
2 Asp130Lys+R1 0.0338 ± 0.002 574 ± 88 58.9 ± 12.5  
3 Ile168Met+R2 0.0359 ± 0.00076 227 ± 16 158.1 ± 14.5 
4 Gly199Ala+R3 0.1059 ± 0.0038 397 ± 39 266.7 ± 35.7 
5 Tyr167Lys+R4 0.30908 ± 0.036 767 ± 188   403.0 ± 145.7 
 
As we have shown previously34, the electrostatic free energy of stabilization of the transition 
state, Δ𝐺).)89  going from the EL to EL† state can be calculated using Eq. (2) Δ𝐺).)89 = −0.048(?̅?ABC ∙ 𝐸EABC − ?̅?AB ∙ 𝐸EAB)                                       (2) 
where 𝐸EABC,  ?̅?ABC, 𝐸EAB, and ?̅?AB is the electric field (in MV/cm) and bond dipole moment (in 
Debye) in the transition state (EL†) and ligand bound state (EL), respectively, and the factor of 
0.048 converts the free energy into units of kcal/mole. The Δ𝐺).)89  will primarily direct mutations 
that will benefit kcat trends as estimated through transition state theory 𝑘80G ∝ 	 𝑒JKLMNONP‡ = 𝑒JKLMRSTN‡ 𝑒JKLMSPUVWN‡ 𝑒JKLMXUYNZ‡    (3) 
where we have decomposed Δ𝐺).)89  into terms that emphasize the free energy stabilization of 
electric fields from the catalytic base, Δ𝐺"0[)9 , the active site, Δ𝐺08G#\)9 , and the rest of the protein 
scaffold as well as solvent, Δ𝐺]G^)_9 . The ligand binding energy terms calculated with Eq. (1) 
were used to analyze KM trends.  
 Figure 3a show the electric field contribution to each bond from the individual residues of 
the KE15 designed sequence in the EL† state, and Table 2 shows the breakdown of electrostatic 
free energy changes between the EL and EL† contributions for the catalytic base, active site, 
remaining protein scaffold, and solvent for the KE15 design; we also include the reference state 
of the electric field stabilization for each bond of the substrate in aqueous solvent. It is clear that 
the catalytic base (Asp48) is the only residue with the largest productive electric field 
contribution to the making and breaking of bonds of the 5-nitrobenzisoxazole substrate, whereas 
the rest of the scaffold and enzyme solvent plays a small or even counterproductive role for 
transition state stabilization, consistent with what we found for KE07 and KE7034. 
a.       b. 
 
Figure 3. Individual residue contribution to the electric field, 𝐸EABC of the (a) KE15 design and 
(b) KE15 Asp130Lys mutation at the transition state. Electric projections are shown for the C-H 
(green), CºN (red) and O-N (black) bonds of the ligand. The water contributes -3.8, 20.4 and -
18.0 MV/cm for the KE15 design CH, CN and ON bonds respectively, while contributing -2.0, 
1.0 and -14.4 MV/cm for the KE15 Asp130Lys mutant. KE15 contains a total of 253 residues. 
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Table 2: Breakdown of 𝛥𝐺).)89  from the different regions of the protein and solvent for the 
designed and computationally evolved enzymes and the calculated binding energy, Ebind, of the 
ligand in the enzyme. The free energy contribution (kcal/mole) from the electric field at each of 
the substrate bonds (Fig. 2) using Eq. (2), for the designed KE15 and computationally improved 
variants. The active site is defined by residues within 5 Å from the substrate (see SI for residue 
numbers), while the protein environment is summed over all residues outside this region. Solvent 
includes waters in the neck of the TIM barrel as well as the surrounding hydration and bulk 
water. The binding energy is calculated using Eq. (1). The reference energy is the electric field 
contribution on each bond from aqueous solution (no enzyme). 
Bond 𝚫𝑮𝒆𝒍𝒆𝒄9  (kcal/mole) 
C-H KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
Base -4.6 -4.1 -5.8 -6.7 -8.6 
Active 0.1 0.1 -0.1 0.5 -0.6 
Protein -1.0 -0.9 -0.9 -0.5 0.0 
Solvent 0.1 -0.3 0.3 0.7 1.4 
Total -5.4 -5.2 -6.5 -6.0 -7.8 
Reference -3.6 
  
C-N KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
Base 2.0 0.4 0.9 0.9 2.1 
Active 0.0 0.3 0.3 0.3 -0.2 
Protein 0.8 0.8 0.6 1.1 1.5 
Solvent 0.2 0.5 0.6 0.0 -0.5 
Total 3.0 2.1 2.4 2.3 2.9 
Reference 2.3 
 
O-N KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
Base -6.0 -5.2 -6.3 -7.5 -7.9 
Active 1.1 0.7 0.8 1.9 0.6 
Protein -1.6 -1.1 -1.3 -0.2 0.7 
Solvent 3.2 2.5 3.3 3.2 3.1 
Total -3.3 -3.1 -3.5 -2.6 -3.5 
Reference -0.9 
 
Net Base -8.6 -8.9 -11.2 -13.3 -14.4 
Net Active 1.2 1.1 1.0 2.7 -0.2 
Net Protein -1.8 -1.2 -1.6 0.4 2.2 
Net Solvent 3.5 2.7 4.2 3.9 4.0 
      
Net 𝚫𝑮𝒆𝒍𝒆𝒄9  -5.7 -6.3 -7.6 -6.3 -8.4 
Net reference -2.2 
      
Ebind (kcal/mole) 
unconstrained -26.9 ± 2.2 -26.1 ± 2.0 -27.8 ± 1.9 -23.0 ± 1.9 -17.2 ± 1.7 
constrained  -30.5 ± 1.4 -34.7 ± 1.6   
 
 
 However, the magnitude of ~35-50 MV/cm, depending on chemical bond of the substrate 
as seen in Table 3, from Asp48 is under half the electric field value than we found for the 
corresponding catalytic base Glu101 for the KE07 enzyme, and is still small relative to the 
values contributed by the His-Asp dyad for KE70, making Δ𝐺"0[)9  for KE15 much smaller than 
the KE07 and KE70 designs34. Furthermore, all other KE15 residues and enzyme solvent show 
only minimal electric field contributions to the 3 substrate bonds, with only a few residues 
exhibiting contributions of around ~ ±7 MV/cm at most. This is unlike what we previously 
observed for the KE07 and KE70 designs where many residues and solvent electric field 
contributions were much larger (anywhere between ±10 MV/cm and ±50 MV/cm), and thereby 
contributed much larger Δ𝐺]G^)_9  contributions to stabilization or destabilization.34  
 
Table 3: Electric field contributions by region for KE15 designed and computationally evolved 
enzymes. The magnitude of the electric field at the C-H, C-N, and O-N bond in either the EL and 
EL† states for the designed KE15 and computationally improved variants. The active site is 
defined by residues within 5 Å from the substrate (see main text for residue numbers), while the 
protein environment is summed over all residues outside this region. Solvent includes waters in 
the neck of the TIM barrel as well as the surrounding hydration and bulk water. Positive	sign	indicates	field	supporting	the	reaction	(CH	and	ON	bond	breaking	as	well	as	CN	triple	bond	formation).”Fields are reported in units of MV/cm.  
C-H bond KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
 EL EL† EL EL† EL EL† EL EL† EL EL† 
Base 46.2 49.5 24.8 60.2 36.0 84.0 35.7 104.1 68.4 111.5 
Active -5.9 4.4 -1.7 3.4 -0.0 2.5 -5.0 -5.0 4.6 7.2 
Protein 6.2 15.4 5.2 13.2 6.0 12.6 2.0 9.2 -0.5 1.1 
Solvent -2.4  -3.8 7.5  -2.0  3.5 -8.9 3.3 -18.5 -14.6 -15.3 
 
C-N bond KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
 EL EL† EL EL† EL EL† EL EL† EL EL† 
Base 22.1 6.9 7.8 19.2 14.0 24.4 17.2 38.1 31.4 48.1 
Active 4.2 22.9 7.4 20.5 8.0 22.3 6.9 16.8 1.0 12.8 
Protein 10.1 9.9 13.7 23.9 10.7 22.9 16.4 25.9 21.0 26.3 
Solvent 6.3  20.4 5.7  1.0  6.6 3.4 -1.8 -7.7 -6.7 -8.5 
 
O-N bond KE15 Design 
R1 
Asp130Lys+R1 
R2 
Ile168Met+R2 
R3 
Gly199Ala+R3 
R4 
Tyr167Lys+R4 
R5 
 EL EL† EL EL† EL EL† EL EL† EL EL† 
Base 26.0 35.3 15.2 36.1 14.6 46.3 21.7 52.2 31.6 48.4 
Active -12.2 -1.0 -5.7 -1.7 -10.5 0.5 -14.1 -6.6 -4.1 -2.8 
Protein 4.4 11.0 4.4 6.5 7.1 6.3 1.2 0.7 -3.8 -3.4 
Solvent -15.3  -18.0 -11.1  -14.4  -12.2 -20.8 -9.9 -21.9 -18.2 -14.9 
 
Although kcat only differs by a factor of 3 for the KE07 and KE15 designs, their active sites are 
in completely different parts of the TIM barrel (Figure 4a), which likely explains the differences 
in the electric field magnitudes. Unlike the creation of HG19, which sought to move the active 
site entirely to elsewhere in the protein, we will attempt to maintain the KE15 active site at its 
designed position and instead seek mutations that further improve electrostatic fields. In addition, 
we consider the relative importance of the electric fields emanating from the base and active site 
residues, and compare their free energy contribution to that from the protein scaffold and 
surrounding solvent as embodied in Δ𝐺]G^)_9 .  
 
 
Figure 4. (a) Substrate and ligand position in the TIM barrel for KE07 (pink) and KE15 (grey) 
designs. (b) Location of the 4 mutations of KE15 best variant. Asp130Lys lies in the lower barrel 
of the scaffold; Ile168Met is closer to the substrate but faces outward and away from the ligand, 
unlike Tyr167Lys that faces towards it. Gly199Ala is in more direct contact with the bonds that 
break and form during the reaction and the mutation to a bulkier residue brings the ligand closer 
to the base.” 
 
The largest negative electric field contribution of any residue in the KE15 design is at position 
Asp130 located at the bottom of the TIM barrel relatively far from the substrate, with E= -7.29 
MV/cm when projected onto the CºN bond. Thus, the most unfavorable Δ𝐺).)89  contribution 
arises from Δ𝐺]G^)_9 . Therefore Asp-130 is expected to have a long-range effect on the chemical 
step (Figure 4b) and hence a change of charge rather than hydrophobicity and/or size, seemed 
more likely to increase the electrostatic stabilization of the transition state. Since aspartic acid is 
negatively charged, we tried a neutral (asparagine) and positively charged (lysine) residue in its 
place. Table 2 reports that the mutation Asp130Lys was predicted to significantly increase the 
electric field stabilization of the transition state but with some small degradation in KM as 
estimated from Ebind. This qualitative trend was in fact verified experimentally to yield our first 
best variant with an experimentally measured kcat/KM = 59 M-1s-1, with the bulk of the 
improvement stemming from a factor of 4-5 in kcat as shown in Table 1. Our calculations further 
indicate that Asp130Lys stabilized the transition state via improvement in Δ𝐺).)89  at the CºN 
bond, as intended, but mostly through better positioning of the base as indicated by Δ𝐺"0[)9  
(Tables 2 and 3). 
 The electric field projections by individual residues onto the substrate bonds of the 
transition state for the Asp130Lys mutant enzyme (Figure 3b) does so with even smaller 
magnitudes than the KE15 design, so that it is not possible to rationally select residues for further 
mutation based on electric field contributions alone. Instead we restrict ourselves mostly to the 
residues located near the active site where electrostatic effects will be largest and the search 
space most restricted. This is also a sensible strategy since we have shown in previous work that 
the electric fields emanating from the remainder of the TIM barrel scaffold and surrounding 
solvent are incommensurate with the new engineered active site chemistry, such that the 
electrostatic fields of the remainder of the enzyme and solvent actually disfavor the catalytic 
reaction.16, 34 In addition, we concluded that chemical positioning of the ligand relative to the 
catalytic base is a requirement for optimal electric field alignment, and contributed most to 
changes in catalytic activity, which is largely dictated locally at the active site.34 Active site 
residues, defined as within 5 Å of the substrate includes positions 5, 46, 48, 78, 101, 126, 167, 
168, 169, 197, 198, 199, 201, 220. We analyzed these positions for both detrimental (albeit 
small) electrostatic contributions and/or ligand positioning relative to the catalytic base.  
 One active site residue, Ile-168, contributes negatively to the electric field at the 
transition state, albeit with small values of E=-1.67 and -2.97 MV/cm, for the C-H and O-N 
bonds, respectively. Ile-168 is closer to the substrate than Asp-130 but faces away from the 
ligand as shown in Figure 4b, indicating an indirect effect on catalysis. Steric hindrance 
prevented the replacement of isoleucine with bulkier residues than methionine, and the 
Ile168Met mutation was predicted to further stabilize the transition state by ~1.3 kcal/mol and a 
corresponding improvement of ~1.7 kcal/mol in the calculated Ebind (Table 2). Experimentally, 
Ile168Met showed improved performance, but mostly through KM, suggesting a tuning of 
substrate binding instead. Although our binding calculations do indeed capture a larger effect for 
changes in KM for this mutant, the projected electric fields that are primarily designed to capture 
changes in kcat had predicted more improvements in catalysis than was actually found from 
experiment. 
 To better understand this apparent discrepancy, we analyzed the MD trajectories from 
which we compute the electric fields to determine the distance between the ligand and the 
catalytic base. We found that, on average, the mutation Ile168Met resulted in the decrease of the 
distance between the oxygen of the base and the hydrogen of the ligand by almost 1.0 Å through 
reduction in size of the active site. However, a shorter base-ligand separation might result in both 
a more favorable binding as well as enhancement of electric fields. To better separate electric 
field enhancement vs. better substrate binding, we ran a test simulation in which the ligand was 
restrained to remain in close proximity to the base (see Methods for details). We observe that 
when the ligand is restrained, there is no apparent electrostatic stabilization going from round 2 
(the Asp130Lys enzyme) to round 3 (which builds on round 2 with the addition of Ile168Met) 
(Table S2 in Supporting Information). However, the binding affinity does indeed increase (Table 
2), reasonably reconciling theory with experiments. 
 It is interesting to note that the magnitude of the electric fields roughly doubles for all 
three bonds in the simulations when the ligand is restrained close to the base (Table S2). This 
motivated the design of a mutation that would actually bring the ligand closer to the base, as in 
the restrained simulations. Active site residue Gly199 is advantageously positioned for that 
purpose as illustrated in Figure 4b, and we found that mutation of Gly199Ala showed further 
reduction in the distance between the ligand and the base (an additional 0.5 Å compared to round 
3). This is borne out in the large increase in the electric field coming from the base for the C-H 
and N-O bonds (Table 3) and a corresponding large increase in stabilization of Δ𝐺"0[)9 ~2.0 
kcal/mole as given in Table 2.  
 However, this increase is accompanied by a decrease in the contribution of the rest of the 
active site and scaffold and solvent where Δ𝐺08G#\)9 + Δ𝐺]G^)_9  is destabilizing by ~3.4 kcal/mole 
such that the overall electrostatic free energy of stabilization is in fact calculated to be lower than 
for round 3 (Table 2). Experimentally, round 4 has improved performance with a significant 
increase in kcat and only a slight increase in KM (in qualitative but not quantitative agreement 
with Ebind). This means that the predicted enhancement of the contribution of the catalytic base 
actually overcomes the other detrimental changes, indicating that Δ𝐺"0[)9  is more predictive than 
is Δ𝐺).)89  for improving kcat. 
 For round 5, we set to correct for the disadvantages of Gly199Ala, i.e. reduction in the 
electric field contribution of the active site, while keeping its benefits from Δ𝐺"0[)9 , through 
optimization of Δ𝐺08G#\)9 . Therefore, we target residues that are contributing negatively to the 
electric field when the ligand is constrained to be close to the base in round 3 to identify a new 
active site residue, Tyr-167 that is characterized by a negative contribution to the electric field 
(E= -3.04 MV/cm) for the N-O bond. In Figure 4b, we see that Tyr-167 is located at the other 
end of the ligand, near the NO2 group, which is ideal to minimize the impact of this mutation on 
the position of the Asp48 base that is closest to the C-H ligand bond. Set to improve electrostatic 
interactions for the active site, we changed the charge of the residue and found that Tyr167Lys is 
predicted to stabilize the transition state by ~2 kcal/mol compared to round 4 and around ~1 
kcal/mol compared to round 3 (Table 2). Furthermore, we see in Table 2 that both Δ𝐺"0[)9  and Δ𝐺08G#\)9  improve significantly, with the latter being much better optimized and contributing a 
majority to Δ𝐺).)89 . Experiments are in line with these predictions, and round 5 shows the best 
efficiency yet, with a 43-fold improvement in kcat compared to the KE15 design and an overall 
efficiency of 403 M-1s-1.   
 
DISCUSSION  
With just 4 mutations we have improved KE15 to an efficiency that is comparable to the 
performance enhancements that was observed for KE07 and KE70 using LDE, and based on the 
iterative computational design approach used by Privett and co-workers to create HG39. In the 
latter case, the largest improvement stemmed from repositioning the active site to a different part 
of the protein, to isolate the base from solvent in a more hydrophobic pocket to increase its pKa, 
followed by optimization of conformational dynamics in the active site, resulting in ~20 
mutations.9 Our computational approach is very different in the retention of the designed active 
site position, but evolving the electrostatic environment to create much larger electric fields that 
are better aligned to promote bond making and breaking of the substrate using much fewer 
mutations (Table 3). Although we observe modest reactant state destabilization, most of our 
improvements in catalytic rates come through transition state stabilization as summarized 
graphically in Figure 5 and in Table S3. 
  
 
 
 
Figure 5: Electrostatic free energy diagram of 
KE15 and all improved mutants predicted from 
electrostatic calculations. While we observe 
moderate ground state destabilization going from 
R1 to R2 and R4 to R5, most of the free energy 
improvements reported in the main text come from 
transition state stabilization.  			
 
 
 
 
 Furthermore, as discussed previously by Fuxreiter and Mones13, there are other design 
principles derived from our understanding of the catalytic power of natural enzymes that can be 
applied to the designed enzyme KE15 and our improved enzymes using optimization of 
electrostatics and substrate optimization in the active site.. It would be a fruitful line of inquiry in 
future work to explore how changes in structural reorganization energy54-55 and reorganization 
energy based on Marcus theory used by Labas and co-workers17 could help understand how these 
quantities vary among our mutants, and how we might consider all design principles 
simultaneously. It is also interesting that when LDE was applied to HG3, the evolved enzyme 
was improved by three orders of magnitude.10 Since our computational improvement in the 
KE15 enzyme starts from a very different active site and its optimization approach through 
electrostatics, it would be interesting to explore whether LDE can build upon our computational 
design of KE15-4 to reach the catalytic efficiency of HG-17. Finally, we note that the concepts 
and arguments presented in this study to improve KE15 could be used with a different theoretical 
model. In particular, although basic electrostatic effects are appropriately accounted for with a 
classical force field approach, a quantum description of at least part of the system would allow a 
more accurate continuous electric potential to be computed, with appropriate accounting of 
charge penetration and charge transfer effects not represented in the AMOEBA force field. 
CONCLUSIONS  
We have used information about electric fields and chemical positioning of the substrate in the 
active site to create a computationally designed Kemp Eliminase enzyme that has improved kcat 
from 0.007 s-1 to 0.31 s-1 using only 4 mutations. We have drawn several conclusions in regards 
future computational design strategies for de novo enzymes in the future. First is that there is a 
strong interplay between electric field enhancements and chemical positioning, since the latter 
must be optimized in order for the electric field alignment to be maximized. Second, any active 
site position can be rescued through electric field enhancements of the key players in the active 
site, especially from the catalytic base. Finally we have found that computational improvements 
emanating from the arbitrary scaffold of the designed enzyme continue to be a limitation36, in 
contrast to natural enzymes have a scaffold that is pre-organized to be more commensurate with 
the active site.26 Our electric field and chemical positioning strategy has proven to be 
complementary to the iterative approach used by Privett et al.9 for HG3, which focused on 
repositioning the active site and increasing its hydrophobicity, and to Labas and co-workers17 
who suggested that LDE could be replaced by computational optimization of reorganization 
energy instead. There are now many proven computational strategies for optimization of de novo 
enzymes that can be used in future enzyme design work. 
SUPPORTING INFORMATION. Bond dipole moments and electric field values for specific 
regions at the 3 bonds. 
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